Shc and Enigma Are Both Required for Mitogenic Signaling by Ret/ptc2

REFERENCES

• Asai, N., H. Murakami, T. Iwashita, and M. Takahashi 1996. A mutation at tyrosine 1062 in MEN2A-Ret and MEN2B-Ret impairs their transforming activity and association with Shc adaptor proteins. J. Biol. Chem. 271: 17644–17649.
   PubMedGoogle Scholar
• Attie, T., A. Pelet, P. Sarda, P. Edery, C. Eng, L. M. Mulligan, B. A. J. Ponder, A. Munnich, and S. Lyonnet 1994. A 7bp deletion of the RET proto-oncogene mutations in familial Hirschsprung’s disease. Hum. Mol. Genet. 3: 1439–1440.
   PubMedGoogle Scholar
• Ausubel, F., R. Brent, R. Kingston, D. Moore, J. Seidman, J. Smith, and K. Struhl 1994. Current protocols in molecular biology. John Wiley & Sons, Inc., New York, N.Y.
   Google Scholar
• Bongarzone, I., M. G. Butti, S. Coronelli, M. G. Borrello, M. Santoro, P. Mondellini, S. Pilotti, A. Fusco, G. Della Porta, and M. A. Pierotti 1994. Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas. Cancer Res. 54: 2979–2985.
   PubMed Web of Science ®Google Scholar
• Bongarzone, I., N. Monzini, M. G. Borrello, C. Carcano, G. Ferraresi, E. Arighi, P. Mondellini, G. Della Porta, and M. A. Pierotti 1993. Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RIα of cyclic AMP-dependent protein kinase A. Mol. Cell. Biol. 13: 358–366.
   PubMedGoogle Scholar
• Borrello, M. G., L. Alberti, E. Arighi, I. Bongarzone, C. Battistini, A. Bardelli, B. Pasini, C. Piutti, M. G. Rizzetti, P. Mondellini, M. T. Radice, and M. A. Pierotti 1996. The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase Cγ. Mol. Cell. Biol. 16: 2151–2163.
   PubMed Web of Science ®Google Scholar
• Buj-Bello, A., J. Adu, L. G. Pinon, A. Horton, J. Thompson, A. Rosenthal, M. Chinchetru, V. L. Buchman, and A. M. Davies 1997. Neurturin responsiveness requires a GPI-linked receptor and the Ret receptor tyrosine kinase. Nature 387: 721–724.
   PubMedGoogle Scholar
• Cai, H., J. Szeberenyi, and G. M. Cooper 1990. Effect of a dominant inhibitory HA-ras mutation on mitogenic signal transduction in NIH 3T3 cells. Mol. Cell. Biol. 10: 5314–5323.
   PubMed Web of Science ®Google Scholar
• Chen, C., and H. Okayama 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7: 2745–2752.
   PubMed Web of Science ®Google Scholar
• Cross, F. R., E. A. Garber, D. Pellman, and H. Hanafusa 1984. A short sequence in the p60src N terminus is required for p60src myristylation and membrane association and for cell transformation. Mol. Cell. Biol. 4: 1834–1842.
   PubMed Web of Science ®Google Scholar
• Dong, H., R. J. O’Brien, E. T. Fung, A. A. Lanahan, P. F. Worley, and R. L. Huganir 1997. GRIP: a synaptic PDZ domain-containing protein that interacts with AMPA receptors. Nature 386: 279–284.
   PubMed Web of Science ®Google Scholar
• Durbec, P., C. V. Marcos-Gutierrez, C. Kilkenny, M. Grigoriou, K. Wartiowaara, P. Suvanto, D. Smith, B. Ponder, F. Costantini, M. Saarma, S. Hannu, and V. Pachnis 1996. GDNF signalling through the Ret receptor tyrosine kinase. Nature 381: 789–793.
   PubMed Web of Science ®Google Scholar
• Durick, K., R. Y. Wu, G. N. Gill, and S. S. Taylor 1996. Mitogenic signaling by Ret/ptc2 requires association with Enigma via a LIM domain. J. Biol. Chem. 271: 12691–12694.
   PubMedGoogle Scholar
• Durick, K., V. J. Yao, M. G. Borrello, I. Bongarzone, M. A. Pierotti, and S. S. Taylor 1995. Tyrosines outside the kinase core and dimerization are required for the mitogenic activity of RET/ptc2. J. Biol. Chem. 270: 24642–24645.
   PubMedGoogle Scholar
• Edery, P., S. Lyonnet, L. M. Mulligan, A. Pelet, E. Dow, L. Abel, S. Holder, C. Nihoul-Fekete, B. A. Ponder, and A. Munnich 1994. Mutations of the RET proto-oncogene in Hirschsprung’s disease. Nature 367: 378–380.
   PubMed Web of Science ®Google Scholar
• Egan, S. E., B. W. Giddings, M. W. Brooks, L. Buday, A. M. Sizeland, and R. A. Weinberg 1993. Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature 363: 45–51.
   PubMed Web of Science ®Google Scholar
• Feig, L. A., and G. M. Cooper 1988. Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP. Mol. Cell. Biol. 8: 3235–3243.
   PubMed Web of Science ®Google Scholar
• Grieco, M., M. Santoro, M. T. Berlingieri, R. M. Melillo, R. Donghi, I. Bongarzone, M. A. Pierotti, G. Della Porta, A. Fusco, and G. Vecchio 1990. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell 60: 557–563.
   PubMed Web of Science ®Google Scholar
• Gustafson, T. A., W. He, A. Craparo, C. D. Schaub, and T. J. O’Neill 1995. Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate 1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain. Mol. Cell. Biol. 15: 2500–2508.
   PubMed Web of Science ®Google Scholar
• Harrison, S. C. 1996. Peptide-surface association: the case of PDZ and PTB domains. Cell 86: 341–343.
   PubMedGoogle Scholar
• Henderson, C. E., H. S. Phillips, R. A. Pollock, A. M. Davies, C. Lemeulle, M. Armanini, L. C. Simpson, B. Moffet, R. A. Vandlen, V. E. Koliatsos, and A. Rosenthal 1994. GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science 266: 1062–1064.
   PubMed Web of Science ®Google Scholar
• Huang, L. J., K. Durick, J. A. Weiner, J. Chun, and S. S. Taylor 1997. Identification of a novel protein kinase A anchoring protein that binds both type I and type II regulatory subunits. J. Biol. Chem. 272: 8057–8064.
   PubMed Web of Science ®Google Scholar
• Jhiang, S. M., J. E. Sagartz, Q. Tong, J. Parker-Thornburg, C. C. Capen, J. Y. Cho, S. Xing, and C. Ledent 1996. Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas. Endocrinology 137: 375–378.
   PubMed Web of Science ®Google Scholar
• Jing, S., D. Wen, Y. Yu, P. L. Hoist, Y. Luo, M. Fang, R. Tamir, L. Antonio, Z. Hu, R. Cupples, J. Louis, S. Hu, B. W. Altrock, and G. M. Fox 1996. GDNF-induced activation of the Ret protein tyrosine kinase is mediated by GDNFR-α, a novel receptor for GDNF. Cell 85: 1113–1124.
   PubMed Web of Science ®Google Scholar
• Kamps, M. P., J. E. Buss, and B. M. Sefton 1985. Mutation of NH2-terminal glycine of p60src prevents both myristoylation and morphological transformation. Proc. Natl. Acad. Sci. USA 82: 4625–4628.
   PubMed Web of Science ®Google Scholar
• Klein, R. D., D. Sherman, W. H. Ho, D. Stone, G. L. Bennett, B. Moffat, R. Vandlen, L. Simmons, Q. Gu, J. A. Hongo, B. Devaux, K. Poulsen, M. Armanini, C. Nozaki, N. Asai, A. Goddard, H. Phillips, C. E. Henderson, M. Takahashi, and A. Rosenthal 1997. A GPI-linked protein that interacts with Ret to form a candidate neurturin receptor. Nature 387: 717–721.
   PubMedGoogle Scholar
• Kornau, H. C., L. T. Schenker, M. B. Kennedy, and P. H. Seeburg 1995. Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. Science 269: 1737–1740.
   PubMedGoogle Scholar
• Kotzbauer, P. T., P. A. Lampe, R. O. Heuckeroth, J. P. Golden, D. J. Creedon, E. M. Johnson, and J. Milbrandt 1996. Neurturin, a relative of glial-cell-line-derived neurotrophic factor. Nature 384: 467–470.
   PubMed Web of Science ®Google Scholar
• Kunkel, T. A., K. Benebek, and J. McClary 1991. Efficient site-directed mutagenesis using uracil-containing DNA. Methods Enzymol. 204: 125–139.
   PubMed Web of Science ®Google Scholar
• Kupperman, E., W. Wen, and J. L. Meinkoth 1993. Inhibition of thyrotropin-stimulated DNA synthesis by microinjection of inhibitors of cellular Ras and cyclic AMP-dependent protein kinase. Mol. Cell. Biol. 13: 4477–4484.
   PubMedGoogle Scholar
• Laminet, A. A., G. Apell, L. Conroy, and W. M. Kavanaugh 1996. Affinity, specificity, and kinetics of the interaction of the SHC phosphotyrosine binding domain with asparagine-X-X-phosphotyrosine motifs of growth factor receptors. J. Biol. Chem. 271: 264–269.
   PubMedGoogle Scholar
• Lanzi, C., M. G. Borello, I. Bongarzone, A. Migliazza, A. Fusco, M. Grieco, M. Santoro, R. A. Gambetta, F. Zunino, G. Della Porta, and M. A. Pierotti 1992. Identification of the product of two oncogenic rearranged forms of the RET proto-oncogene in papillary thyroid carcinomas. Oncogene 7: 2189–2194.
   PubMedGoogle Scholar
• Lin, L. H., D. H. Doherty, J. D. Lile, S. Bektesh, and F. Collins 1993. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260: 1130–1132.
   PubMed Web of Science ®Google Scholar
• Lowenstein, E. J., R. J. Daly, A. G. Batzer, W. Li, B. Margolis, R. Lammers, A. Ullrich, E. Y. Skolnik, D. Bar-Sagi, and J. Schlessinger 1992. The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell 70: 431–442.
   PubMed Web of Science ®Google Scholar
• Moore, M. W., R. D. Klein, I. Farinas, H. Sauer, M. Armanini, H. Phillips, L. F. Reichardt, A. M. Ryan, K. Carver-Moore, and A. Rosenthal 1996. Renal and neuronal abnormalities in mice lacking GDNF. Nature 382: 76–79.
   PubMed Web of Science ®Google Scholar
• Muller, B. M., U. Kistner, S. Kindler, W. J. Chung, S. Kuhlendahl, S. D. Fenster, L. F. Lau, R. W. Veh, R. L. Huganir, and E. D. Gundelfinger 1996. SAP102, a novel postsynaptic protein that interacts with NMDA receptor complexes in vivo. Neuron 17: 255–265.
   PubMed Web of Science ®Google Scholar
• Mulligan, L. M., C. Eng, C. S. Healey, D. Clayton, J. B. Kwok, E. Gardner, M. A. Ponder, A. Frilling, C. E. Jackson, H. Lehnert, H. Neumann, S. Thibodeau, and B. Ponder 1994. Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nat. Genet. 6: 70–74.
   PubMed Web of Science ®Google Scholar
• Mulligan, L. M., J. B. J. Kwok, C. S. Healey, M. J. Elsdon, C. Eng, E. Gardner, D. R. Love, S. E. Mole, J. K. Moore, L. Papi, M. A. Ponder, H. Telenius, A. Tunnacliffe, and B. A. J. Ponder 1993. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363: 458–460.
   PubMed Web of Science ®Google Scholar
• Pasini, B., I. Ceccherini, and R. Giovanni 1996. Ret mutations in human disease. Trends Genet. 12: 138–144.
   PubMed Web of Science ®Google Scholar
• Pichel, J. G., L. Shen, H. Z. Sheng, A. Granholm, J. Drago, A. Grinberg, E. J. Lee, S. P. Huang, M. Saarma, B. J. Hoffer, H. Sariola, and H. Westphal 1996. Defects in enteric innervation and kidney development in mice lacking GDNF. Nature 382: 73–76.
   PubMed Web of Science ®Google Scholar
• Pierotti, M. A., M. Santoro, R. B. Jenkins, G. Sozzi, I. Bongarzone, M. Grieco, N. Monzini, M. Miozzo, M. A. Herrmann, A. Fusco, I. D. Hay, G. D. Porta, and G. Vecchio 1992. Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET/PTC. Proc. Natl. Acad. Sci. USA 89: 1616–1620.
   PubMedGoogle Scholar
• Pumiglia, K., Y. H. Chow, J. Fabian, D. Morrison, S. Decker, and R. Jove 1995. Raf-1 N-terminal sequences necessary for Ras-Raf interaction and signal transduction. Mol. Cell. Biol. 15: 398–406.
   PubMedGoogle Scholar
• Romeo, G., P. Ronchetto, Y. Luo, V. Barone, M. Seri, I. Ceccherini, B. Pasini, R. Bocciardi, M. Lerone, H. Kaariainen, and G. Martucciello 1994. Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung’s disease. Nature 367: 377–378.
   PubMed Web of Science ®Google Scholar
• Sanchez, M. P., I. Silos-Santiago, J. Frisen, B. He, S. A. Lira, and M. Barbacid 1996. Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature 382: 70–73.
   PubMed Web of Science ®Google Scholar
• Santoro, M., G. Chiappetta, A. Cerrato, D. Salvatore, L. Zhang, G. Manzo, A. Picone, G. Portella, G. Santelli, G. Vecchio, and A. Fusco 1996. Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice. Oncogene 12: 1821–1826.
   PubMed Web of Science ®Google Scholar
• Santoro, M., N. A. Dathan, M. T. Berlingieri, I. Bongarzone, C. Paulin, M. Grieco, M. A. Pierotti, G. Vecchio, and A. Fusco 1994. Molecular characterization of RET/PTC3; a novel rearranged version of the RET proto-oncogene in a human thyroid papillary carcinoma. Oncogene 9: 509–516.
   PubMed Web of Science ®Google Scholar
• Santoro, M., W. T. Wong, P. Aroca, E. Santos, B. Mat̆os̆kovā, M. Grieco, A. Fusco, and P. P. Di Fiore 1994. An epidermal growth factor receptor/ret chimera generates mitogenic and transforming signals: evidence for a ret-specific signaling pathway. Mol. Cell. Biol. 14: 663–675.
   PubMed Web of Science ®Google Scholar
• Saras, J., and C. H. Heldin 1996. PDZ domains bind carboxy-terminal sequences of target proteins. Trends Biochem. Sci. 21: 455–458.
   PubMed Web of Science ®Google Scholar
• Schuchardt, A., V. D’Agati, L. Larsson-Plomberg, F. Constantini, and V. Pachnis 1994. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 367: 380–383.
   PubMed Web of Science ®Google Scholar
• Simske, J. S., S. M. Kaech, S. A. Harp, and S. K. Kim 1996. LET-23 receptor localization by the cell junction protein LIN-7 during C. elegans vulval induction. Cell 85: 195–204.
   PubMedGoogle Scholar
• Takahashi, M., J. Ritz, and G. M. Cooper 1985. Activation of a novel human transforming gene, ret, by DNA rearrangement. Cell 42: 581–588.
   PubMed Web of Science ®Google Scholar
• Tong, Q., S. Xing, and S. M. Jhiang 1997. Leucine zipper-mediated dimerization is essential for the PTC1 oncogenic activity. J. Biol. Chem. 272: 9043–9047.
   PubMedGoogle Scholar
• Treanor, J. J. S., L. Goodman, F. de Sauvage, D. M. Stone, K. T. Poulsen, C. D. Beck, C. Gray, M. P. Armanini, R. A. Pollock, F. Hefti, H. S. Phillips, A. Goddard, M. W. Moore, A. Buj-Bello, A. M. Davies, N. Asai, M. Takahashi, R. Vandlen, C. E. Henderson, and A. Rosenthal 1996. Characterization of a multicomponent receptor for GDNF. Nature 382: 80–83.
   PubMed Web of Science ®Google Scholar
• Trub, T., W. E. Choi, G. Wolf, E. Ottinger, Y. Chen, M. Weiss, and S. E. Shoelson 1995. Specificity of the PTB domain of Shc for β turn-forming pentapeptide motifs amino-terminal to phosphotyrosine. J. Biol. Chem. 270: 18205–18208.
   PubMedGoogle Scholar
• van der Geer, P., T. Hunter, and R. A. Lindberg 1994. Receptor protein-tyrosine kinases and their signal transduction pathways. Annu. Rev. Cell Biol. 10: 251–337.
   PubMedGoogle Scholar
• Vojtek, A. B., S. M. Hollenberg, and J. A. Cooper 1993. Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell 74: 205–214.
   PubMed Web of Science ®Google Scholar
• Wu, R. Y., K. Durick, Z. Songyang, L. C. Cantley, S. S. Taylor, and G. N. Gill 1996. Specificity of LIM domain interactions with receptor tyrosine kinases. J. Biol. Chem. 271: 15934–15941.
   PubMedGoogle Scholar
• Wu, R. Y., and G. N. Gill 1994. LIM domain recognition of a tyrosine-containing tight turn. J. Biol. Chem. 269: 25085–25090.
   PubMedGoogle Scholar